{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:22:20Z","timestamp":1774567340595,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1086\/324525","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:51:06Z","timestamp":1027702266000},"page":"S4-S16","source":"Crossref","is-referenced-by-count":163,"title":["Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999\u20132000"],"prefix":"10.1093","volume":"34","author":[{"given":"Clyde","family":"Thornsberry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T.","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"key\n\t\t\t\t20171014033843_ref1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/174.5.986","article-title":"The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System","volume":"174","author":"Butler","year":"1996","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3201\/eid0506.990603","article-title":"Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997\u20131998","volume":"5","author":"Doern","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","article-title":"Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the Sentry Antimicrobial Surveillance Program","volume":"27","author":"Doern","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.40.5.1208","article-title":"Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref5","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/45.5.623","article-title":"Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis","volume":"45","author":"Mason","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.45.4.1037-1042.2001","article-title":"Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/jac\/44.6.749","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997\u20131998","volume":"44","author":"Thornsberry","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(97)00195-8","article-title":"Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in the 1996\u20131997 respiratory season","volume":"29","author":"Thornsberry","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref10","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014033843_ref11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","article-title":"The Alexander Project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections","volume":"45","author":"Felmingham","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1179\/joc.1999.11.Supplement-2.5","article-title":"Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens\u2014findings of the Alexander Project 1992\u20131996","volume":"11","author":"Felmingham","year":"1999","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref13","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1128\/AAC.36.10.2176","article-title":"Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States","volume":"36","author":"McDougal","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM197810052991402","article-title":"Emergence of multiply resistant pneumococci","volume":"299","author":"Jacobs","year":"1978","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014033843_ref15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/AAC.41.2.292","article-title":"Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of \u03b2-lactamase positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study","volume":"41","author":"Doern","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref16","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/AAC.40.12.2884","article-title":"Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.43.2.385","article-title":"Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from SENTRY antimicrobial surveillance program (United States and Canada, 1997)","volume":"43","author":"Doern","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref18","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","volume-title":"Approved standard M7-A4","author":"National Committee for Clinical Laboratory Standards","year":"1999"},{"key":"key\n\t\t\t\t20171014033843_ref19","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"9th informational supplement, M100-S9","author":"National Committee for Clinical Laboratory Standards","year":"1999"},{"key":"key\n\t\t\t\t20171014033843_ref20","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"8th informational supplement, M100-S8","author":"National Committee for Clinical Laboratory Standards","year":"1998"},{"key":"key\n\t\t\t\t20171014033843_ref21","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"10th informational supplement, M100-S10","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"key\n\t\t\t\t20171014033843_ref22","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref23","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanism of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996\u20131997) multicenter surveillance study","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref25","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/AAC.39.12.2667","article-title":"Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong","volume":"39","author":"Kam","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/JCM.39.1.367-369.2001","article-title":"Use of penicillin MICs to predict in vitro activity of other \u03b2-lactam antimicrobial agents against Streptococcus pneumoniae","volume":"39","author":"Brueggemann","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014033843_ref27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.34.11.2075","article-title":"Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States","volume":"34","author":"Jorgensen","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014033843_ref28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(96)00135-6","article-title":"Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens","volume":"25","author":"Gr\u00fcneberg","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014033843_ref29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"Beta-lactamases in laboratory and clinical practice","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171014033843_ref30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/AAC.40.4.966","article-title":"Molecular characterization of the BRO \u03b2-lactamase of Moraxella (Branhamella) catarrhalis","volume":"40","author":"Bootsma","year":"1996","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/34\/Supplement_1\/S4\/20904331\/34-Supplement_1-S4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:41:06Z","timestamp":1583293266000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/34\/Supplement_1\/S4\/510965\/Regional-Trends-in-Antimicrobial-Resistance-among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":30,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2002,3,1]]},"published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1086\/324525","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2002,3,1]]},"published":{"date-parts":[[2002,3,1]]}}}